Al-Dawaa Medical Services Company — Cyborg Score 7/10
Strong
Pharmaceutical Retail & Healthcare Services
Strategic Profile
The company operates through three segments: Retail, Wholesale, and Logistics. Al-Dawaa sells its pharmaceutical products through a network of pharmacies, as well as online and wholesale channels, positioning itself as an integrated healthcare services provider with significant distribution reach in Saudi Arabia.
Cyborg Score Rationale
Al-Dawaa demonstrates solid fundamentals with consistent double-digit revenue growth, a dominant market position with 900+ pharmacies across 100+ cities, and a healthy dividend yield. The company shows strategic diversification across retail, wholesale, and logistics with manufacturing capabilities in medical devices.
Top Insights
Company's revenue in the last twelve months is 6.59B SAR, up 12.56% year-over-year, with annual 2024 revenue of 6.45B and 12.36% growth
Customer base has surpassed the five million mark
Al-Dawaa Medical Services dividend yield is 4.59%
The company has five subsidiaries: Al-Dawaa Medical Services Company, Holinx GmbH, Ronzac GmbH, Glanzzen, and Premier Medical Devices Manufacturing Company
Named Competitors
Pharmacy and Medical Retail — Large pharmacy chain competitor in Saudi Arabia
Healthcare Services — Hospital and medical services competitor
Recent Developments
(Mar 2025) Quarterly revenue of 1.65B SAR with 8.85% growth for Q1 FY2025